Drug policies have traditionally sought to suppress supply and deter use through the application of punitive laws. Today, there is a growing recognition that these drug policies have not only failed to reach their objectives but have resulted in a great deal of collateral damage. Drug policy must be reformed to focus on health, human rights and development objectives, with the aim of making the market less harmful rather than necessarily reducing its size.
IDPC provides an overview of the intersections between human rights and drug control as enshrined in the UNGASS Outcome document, offering recommendations for a better articulation of these two spheres of international cooperation.
This event will consider whether stigma is due to misrepresentation - that leads to public misunderstanding of drug use - and whether changing public opinions can lead to the development of improvements in the lives of people who use drugs and in the development of better services for people with a drug problem.
This paper seeks to contribute to understanding of existing policies related to harm reduction in Cambodia, as well as the challenges to and opportunities for improvement in order to reduce the health and socio-economic harms associated with drug use.
This Paper provides an analysis of critical public health problems for the Philippine prison population, in relation to HIV/AIDS and hepatitis C (HCV), and offers recommendations
for addressing these ‘twin epidemics.’
Adapting the UN drug control system to modern realities is long overdue, and if the Board wants to protect the useful elements of the current system, the only option is to facilitate change, through honest discussion and valid guidance.